Provided herein are pharmaceutical compositions comprising transnorsertraline, salts and polymorphic forms thereof a crystalline hydrochloride salt of transnorsertraline or a hydrate thereof as well as the use of the pharmaceutical composition and the salt for the treatment of CNS diseases, including depression.
